Epidermal growth factor receptor signaling pathway involved in progestin‐resistance of human endometrial carcinoma: In a mouse model
Epidermal growth factor receptor signaling pathway involved in progestin‐resistance of human endometrial carcinoma: In a mouse model
复制标题
DOI：
10.1111/j.1447-0756.2012.01881.x
复制
发表时间：
2012-12
影响因子：
1.6
通讯作者：
Yanli Xu;Jianqian Tong;Zhihong Ai;Juan-juan Wang;Y. Teng
中科院分区：
文献类型：
--
作者：
Yanli Xu;Jianqian Tong;Zhihong Ai;Juan-juan Wang;Y. Teng
目的：这些研究的目的是研究吉非替尼（一种特异性口服表皮生长因子受体酪氨酸激酶抑制剂）在人子宫内膜癌异种移植模型中逆转孕酮耐药的作用。
Aim: The aim of these investigations was to study the role of gefitinib (a specific oral epidermal growth factor receptor‐tyrosine kinase inhibitor) on reversing progestin‐resistance in a human endometrial carcinoma xenograft model.